Huamao Mark Lin
- Oncology top 5%
- Lung Cancer Research Studies 22
- Colorectal Cancer Treatments and Studies 10
- Pancreatic and Hepatic Oncology Research 7
-
- Lung Cancer Treatments and Mutations 47
- Lung Cancer Diagnosis and Treatment 13
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 12
- Hematology top 10%
- Multiple Myeloma Research and Treatments 7
-
- Lymphoma Diagnosis and Treatment 7
Huamao Mark Lin
72 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 582
- Pulmonary and Respiratory Medicine 618
- Cancer Research 166
- Hematology 118
- Immunology 128
Countries citing papers authored by Huamao Mark Lin
This map shows the geographic impact of Huamao Mark Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huamao Mark Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huamao Mark Lin more than expected).
Fields of papers citing papers by Huamao Mark Lin
This network shows the impact of papers produced by Huamao Mark Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huamao Mark Lin. The network helps show where Huamao Mark Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huamao Mark Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 7 | |
| 2 | 2024 | 11 | |
| 3 | 2023 | 28 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 25 | |
| 8 | 2023 | 27 | |
| 9 | 2023 | 0 | |
| 10 | 2022 | 17 | |
| 11 | 2022 | 8 | |
| 12 | 2021 | 12 | |
| 13 | 2020 | 47 | |
| 14 | 2019 | 9 | |
| 15 | 2018 | 16 | |
| 16 | 2017 | 1 | |
| 17 | 2016 | 7 | |
| 18 | 2015 | 48 | |
| 19 | 2004 | 47 | |
| 20 | 2001 | 10 |
About Huamao Mark Lin
Huamao Mark Lin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 73 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (47 papers), Lung Cancer Research Studies (22 papers), Lung Cancer Diagnosis and Treatment (13 papers), Cancer Genomics and Diagnostics (12 papers), Colorectal Cancer Treatments and Studies (10 papers), Multiple Myeloma Research and Treatments (7 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). The work is most often cited by research in Oncology (582 citations), Pulmonary and Respiratory Medicine (618 citations) and Cancer Research (166 citations). Huamao Mark Lin has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Barbara E. Bierer, Yu Yin, Jianchang Lin, Danny Nguyen, Sylvie Vincent, Minal Mehta, Shu Jin, Mohammad Jahanzeb, Sai‐Hong Ignatius Ou and Xiaoyun Pan. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.